Evaluating Telehealth Support for Fertility Care in Young Cancer Patients Ages 0 to 50
Led by University of California, San Diego · Updated on 2025-12-03
2800
Participants Needed
4
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a multi-component telehealth intervention designed to improve engagement in goal-aligned oncofertility care among adolescent and young adult cancer patients. The study focuses on young cancer survivors and aims to observe how the intervention is implemented while assessing its impact on their participation in fertility preservation care. This is a phase 3 randomized controlled trial sponsored by the University of California, San Diego.
The intervention group receives a multi-component telehealth oncofertility care program that includes an adaptive electronic health record-based screening and referral system, telehealth counseling, and financial navigation when needed. The control group receives usual oncology care without the added oncofertility intervention. Eligible cancer patients are assigned randomly to either group as they present to oncology visits.
Participants aged from newborns up to 50 years old will be followed, with key outcomes measured 12 weeks after their oncology visit. Researchers will assess how many patients engage in goal-concordant oncofertility care and measure decisional conflict related to fertility choices. The study monitors both male and female patients, with assessments including engagement rates and decision-making clarity regarding fertility preservation options.
CONDITIONS
Brief Title
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
Research Team
H
H. Irene Su, MD, MSCE
S
Sally AD Romero, PhD, MPH
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
Telehealth-based Oncofertility Intervention
Usual Care
What it is
A structured program that uses electronic health record tools to screen fertility-related needs, provide telehealth-based oncofertility counseling, and offer financial navigation as part of cancer care.
The standard process for cancer patients regarding fertility risk counseling and referrals, with care provided according to usual practices at each clinical site.
Role in the trial
Experimental arm: participants receive the multi-component telehealth-based oncofertility care in addition to standard oncology treatment.
Comparator arm: participants receive only the routine standard-of-care fertility counseling and any referrals typically offered at their treatment site.
Primary use or purpose
To increase the number of reproductive-aged patients who receive goal-concordant oncofertility care and to reduce decisional conflict about fertility preservation decisions.
To reflect the current standard for fertility preservation counseling and referrals without additional structured intervention.
How it is given or performed
Delivered through electronic health record-based screening and referral tools, telehealth video counseling for oncofertility needs, and telehealth financial navigation as indicated, integrated into routine oncology care.
Provided according to local site practices, which may include in-person fertility counseling and referral at the discretion of the oncology team, without a structured protocol.
Evidence status in literature
Effectiveness is still under investigation in cancer patients aged 0 to 50 years; prior pilot and cluster randomized studies suggest potential to increase access to goal-concordant oncofertility care, but large-scale outcome data is awaited.
Routine oncofertility counseling and support is the current standard for adolescent and young adult cancer patients, though evidence highlights gaps in delivery, timing, or access.
Important limitations or uncertainties
Access to reliable internet and telehealth technology may be required. The effectiveness in broader and more diverse populations remains under investigation; long-term outcome data are not yet available.
Usual care may vary between sites, and standard practice is associated with inconsistent delivery of fertility counseling and potential missed opportunities for timely preservation discussion.
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 0Years - 50Years
All Genders
Eligibility Criteria
You may qualify if you...
Newly diagnosed cancer or cancer relapse
Primary language English or Spanish
Receiving oncology care at participating clinical sites
Ages 0 to 42 years if female
Ages 0 to 50 years if male
You will not qualify if you...
Non-melanoma skin cancer, because primary treatment is excision with no infertility risk
Metastatic/Stage IV non-thyroid solid tumors, because of poor prognosis
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Outpatient Treatment
Duration - Up to 12 weeks after oncology visit
Participants receive the multi-component oncofertility care intervention including telehealth counseling and financial navigation as indicated.
Oncology clinical visits with telehealth as scheduled
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Phase III Study of Oral Zotiraciclib for Recurrent Malignant Gliomas with IDH1 or IDH2 Mutations
Study of 18F-FAPI-04 PETCT and PETMR Scans for Detecting and Monitoring Various Cancers
18F-grazy-02 PETCT Imaging to Monitor Immunotherapy Responses in Adults with Lung Cancer or Melanoma
Study of 68Ga-NYM096 PETCT Imaging to Measure Tracer Uptake in Different Types of Cancer Including Primary and Metastatic Tumors
PET Imaging Using 68GaGa-Sa-DABI-4 to Detect Stimulator of Interferon Gene Expression in Adults with Cancer
Behavioral Intervention to Help Young LatinoHispanic Men with Cancer Manage Emotions and Life Goals
Prospective Clinical and Biological Database of Cancer Patients Starting Anticancer Immunotherapy
Tracking Immune-Related Side Effects Over Time
Phase I Trial Evaluating Safety and Dose of PA5 Intravenous Treatment for Adults With Advanced Solid Tumors
Online Platform for Sharing Cancer Patient Information
To Support Treatment Decisions and Accelerate Research
Study of a Decision Support Program for Older Adults 60 with Acute Myeloid Leukemia and Their Caregivers
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Let's TOC Fertility: A stepped wedge cluster randomized controlled trial of the Telehealth Oncofertility Care (TOC) intervention in children, adolescent and young adult cancer survivors.
Sally A D Romero, Lauren Au, Ricardo E Flores-Ortega...